Altmeyer Anne 4
4 · Corbus Pharmaceuticals Holdings, Inc. · Filed May 21, 2026
Research Summary
AI-generated summary of this filing
Corbus (CRBP) Director Anne Altmeyer Receives RSU Award
What Happened Anne Altmeyer, a director of Corbus Pharmaceuticals Holdings, received equity compensation on May 19, 2026. The Form 4 reports (1) 3,800 restricted stock units (RSUs) granted (acquired at $0.00) and (2) 12,300 derivative award units (also $0.00). These are awards/grants (transaction code A), not open-market purchases or sales, so they reflect compensation/awards rather than a buy or sell.
Key Details
- Transaction date: 2026-05-19; reported on Form 4 filed 2026-05-21 (filing appears timely).
- Price: $0.00 per share (standard for grants/RSUs).
- Vesting: The 3,800 RSUs vest 100% on the one-year anniversary of the grant (Footnote F1). The derivative amount includes previously reported unvested RSUs (Footnote F2). Footnote F3 notes the award was made under the issuer’s 2024 Equity Compensation Plan and vests 100% after one year.
- Shares owned after the transaction: not disclosed in the filing.
- Transaction type: Award/Grant (A). No sale, purchase (cash), or immediate exercise/sale reported.
Context These grants are compensation/retention awards that convert to common shares only if/when they vest; they are not an immediate cash purchase or sale. Derivative entries here represent RSU-type awards that will settle into shares per the vesting schedule. As with most grant filings, this is informational about insider compensation rather than an express market signal.
Insider Transaction Report
- Award
Common Stock, par value $0.0001 per share
[F1][F2]2026-05-19+3,800→ 9,991 total - Award
Stock options (right to buy)
[F3]2026-05-19+12,300→ 12,300 totalExercise: $9.15Exp: 2026-05-19→ Common Stock (12,300 underlying)
Footnotes (3)
- [F1]On May 19, 2026, 3,800 restricted stock units ("RSUs") were granted, which will be settled in shares of common stock, par value $0.0001. The RSUs will vest 100% on the one-year anniversary from the date of grant.
- [F2]This amount includes 8,600 unvested RSUs subject to each grant's vesting schedule as previously reported.
- [F3]The option award was made in accordance with the terms of the issuer's 2024 Equity Compensation Plan. The option will vest 100% on the one-year anniversary from the date of grant.